{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:41:26Z","timestamp":1788234086434,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111441","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T11:56:25Z","timestamp":1614426985000},"page":"111441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury"],"prefix":"10.1016","volume":"138","author":[{"given":"Song","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-li","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111441_bib1","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/nu12082364","article-title":"Gut microbiota associations with metabolic health and obesity status in older adults","volume":"12","author":"Zhong","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.111441_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12998\/wjcc.v6.i4.54","article-title":"Correlations between microbial communities in stool and clinical indicators in patients with metabolic syndrome","volume":"6","author":"Lin","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.biopha.2021.111441_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.111441_bib4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/1462-2920.13692","article-title":"Meta-analysis of the human gut microbiome from urbanized and pre-agricultural populations","volume":"19","author":"Mancabelli","year":"2017","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.biopha.2021.111441_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro.2017.149","article-title":"Microbial modulation of cardiovascular disease","volume":"16","author":"Brown","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2021.111441_bib6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1126\/science.aau5812","article-title":"The gut microbiota at the intersection of diet and human health","volume":"362","author":"Gentile","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111441_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2021.111441_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111441_bib9","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2021.111441_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.chom.2016.03.003","article-title":"Intrinsic defense mechanisms of the intestinal epithelium","volume":"19","author":"Ramanan","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2021.111441_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/advances\/nmz061","article-title":"Negative effects of a high-fat diet on intestinal permeability: a review","volume":"11","author":"Rohr","year":"2020","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.biopha.2021.111441_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2021.111441_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.phrs.2019.02.024","article-title":"Gut microbiota, a new frontier to understand traditional Chinese medicines","volume":"142","author":"Feng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111441_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jphs.2017.11.007","article-title":"Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy","volume":"136","author":"Gong","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2021.111441_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2019.04.202","article-title":"Akebia saponin D inhibits the formation of atherosclerosis in ApoE(-\/-) mice by attenuating oxidative stress-induced apoptosis in endothelial cells","volume":"285","author":"Yang","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2021.111441_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1124\/jpet.116.236562","article-title":"Akebia saponin D decreases hepatic steatosis through autophagy modulation","volume":"359","author":"Gong","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.111441_bib17","article-title":"Akebia saponin D regulates the metabolome and intestinal microbiota in high fat diet-induced hyperlipidemic rats","volume":"24","author":"Zhou","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111441_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2018.11.038","article-title":"Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D","volume":"845","author":"Gong","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111441_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112815","article-title":"A sensitive and efficient method for simultaneous profiling of bile acids and fatty acids by UPLC-MS\/MS","volume":"178","author":"Hu","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2021.111441_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mcna.2011.06.001","article-title":"The metabolic syndrome--from insulin resistance to obesity and diabetes","volume":"95","author":"Gallagher","year":"2011","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.biopha.2021.111441_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"Ko","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111441_bib22","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.111441_bib23","doi-asserted-by":"crossref","first-page":"72439","DOI":"10.1039\/C6RA14427F","article-title":"Enhancement of oral bioavailability of akebia saponin D by destroying self-micelles and inhibiting multidrug resistance-associated protein mediated efflux","volume":"6","author":"Shen","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2021.111441_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/03639045.2018.1526183","article-title":"Mechanism of enhanced oral absorption of akebia saponin D by a self-nanoemulsifying drug delivery system loaded with phospholipid complex","volume":"45","author":"Wang","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2021.111441_bib25","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.2147\/IJN.S108765","article-title":"Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex","volume":"11","author":"Shen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2021.111441_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nature11400","article-title":"Antibiotics in early life alter the murine colonic microbiome and adiposity","volume":"488","author":"Cho","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111441_bib27","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"Plos Biol."},{"key":"10.1016\/j.biopha.2021.111441_bib28","first-page":"1","article-title":"Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies","author":"Duan","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2021.111441_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2021.111441_bib30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1365-2672.2005.02600.x","article-title":"Getting better with bifidobacteria","volume":"98","author":"Leahy","year":"2005","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biopha.2021.111441_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/19490976.2017.1405209","article-title":"Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice","volume":"9","author":"Lee","year":"2018","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2021.111441_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2018.05.012","article-title":"Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism","volume":"134","author":"Liu","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111441_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2021.111441_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10369-z","article-title":"Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets","volume":"7","author":"Walker","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111441_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/mmi.14445","article-title":"Fatty acid activation and utilization by Alistipes finegoldii, a representative bacteroidetes resident of the human gut microbiome","volume":"113","author":"Radka","year":"2020","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biopha.2021.111441_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chom.2019.10.016","article-title":"A listeria monocytogenes bacteriocin can target the commensal Prevotella copri and modulate intestinal infection","volume":"26","author":"Rolhion","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biopha.2021.111441_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2019.108939","article-title":"Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice","volume":"130","author":"Cai","year":"2020","journal-title":"Food Res. Int."},{"key":"10.1016\/j.biopha.2021.111441_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.111441_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cmet.2015.06.001","article-title":"The gut microbiota regulates intestinal CD4 T cells expressing ROR\u03b3t and controls metabolic disease","volume":"22","author":"Garidou","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2021.111441_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.111441_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jss.2006.07.050","article-title":"Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis","volume":"140","author":"Poritz","year":"2007","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.biopha.2021.111441_bib42","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.111441_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2021.111441_bib44","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2021.111441_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/nu8030128","article-title":"An increase in the omega-6\/omega-3 fatty acid ratio increases the risk for obesity","volume":"8","author":"Simopoulos","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2021.111441_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15646-6","article-title":"Dietary lipids fuel GPX4-restricted enteritis resembling Crohn\u2019s disease","volume":"11","author":"Mayr","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2021.111441_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2021.111441_bib48","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs-mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2021.111441_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.137382","article-title":"Perturbation of the lipid metabolism and intestinal inflammation in growing pigs with low birth weight is associated with the alterations of gut microbiota","volume":"719","author":"Huang","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.biopha.2021.111441_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00282-16","article-title":"FABP4\/aP2 regulates macrophage redox signaling and inflammasome activation via control of UCP2","volume":"37","author":"Steen","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2021.111441_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104519","article-title":"Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism","volume":"151","author":"Suguro","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111441_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7591840","article-title":"Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K\/Akt-mediated Nrf2 signaling pathway","volume":"2019","author":"Zhuang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2021.111441_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.envpol.2018.06.062","article-title":"OTA induces intestinal epithelial barrier dysfunction and tight junction disruption in IPEC-J2 cells through ROS\/Ca(2+)-mediated MLCK activation","volume":"242","author":"Wang","year":"2018","journal-title":"Environ. Pollut."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:13:56Z","timestamp":1760098436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":53,"alternative-id":["S0753332221002262"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111441","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111441"}}